Rivizor – A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure

Publisher: Karger

E-ISSN: 1423-0232|56|2|114-121

ISSN: 0030-2414

Source: Oncology, Vol.56, Iss.2, 1999-02, pp. : 114-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract